tiprankstipranks
Trending News
More News >
Captor Therapeutics SA (PL:CTX)
STUTTGART:CTX
Poland Market

Captor Therapeutics SA (CTX) Income Statement

Compare
0 Followers

Captor Therapeutics SA Income Statement

Last quarter (Q3 2025), Captor Therapeutics SA's total revenue was zł0.00, a decrease of -100.00% from the same quarter last year. In Q3, Captor Therapeutics SA's net income was zł-11.48M. See Captor Therapeutics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
zł 15.82Mzł 13.20Mzł 9.16Mzł 3.99Mzł 0.00
Gross Profit
zł 6.42Mzł 6.90Mzł 7.07Mzł 3.25Mzł -6.60M
Operating Expenses
zł 51.18Mzł 79.92Mzł 45.44Mzł 34.95Mzł 26.85M
Depreciation and Amortization
zł 5.06Mzł 5.44Mzł 7.09Mzł 7.36Mzł 6.60M
EBITDA
zł -32.93Mzł -64.76Mzł -28.22Mzł -24.41Mzł -5.70M
Operating Income
zł -44.76Mzł -73.02Mzł -38.36Mzł -31.71Mzł -12.22M
Other Income/Expenses
zł 541.00Kzł 2.49Mzł 2.47Mzł -863.00Kzł 20.76M
Pretax Income
zł -38.43Mzł -70.53Mzł -35.89Mzł -32.57Mzł -12.69M
Net Income
zł -38.43Mzł -70.58Mzł -35.89Mzł -32.57Mzł -13.09M
Per Share Metrics
Basic EPS
zł -8.25zł -15.19zł -8.61zł -7.89zł -3.90
Diluted EPS
zł -8.25zł -15.19zł -8.61zł -7.89zł -3.90
Weighted Average Shares Outstanding
4.66M 4.65M 4.17M 4.13M 3.26M
Weighted Average Shares Outstanding (Diluted)
4.66M 4.65M 4.17M 4.13M 3.26M
Currency in PLN

Captor Therapeutics SA Earnings and Revenue History